OLMA
Olema Pharmaceuticals Inc
8.80$
-8.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.4% | -4.8% | -3.5% | -9.6% | +95.9% | -9.2% | -6.7% | -7.7% | +51.3% | -0.5% | -8.3% | |
| – | -5.5% | -5.4% | -3.9% | -10.0% | +101.1% | -9.5% | -7.3% | -9.1% | +54.2% | -0.4% | -8.4% | |
| – | -41.6% | -50.8% | -49.9% | +112.5% | +288.7% | -63.7% | +3.6% | -32.8% | +37.0% | +8.8% | -7.5% | |
| – | -5.5% | -4.9% | -4.0% | -10.2% | +102.1% | -9.5% | -7.8% | -9.1% | +53.6% | 0.0% | -8.8% | |
| – | -9.1% | -1.3% | +23.6% | -16.3% | +208.6% | -9.4% | +43.0% | +8.2% | +36.5% | -17.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +8.2% | +8.4% | – | – | – | – | |
| – | +30.5% | +18.8% | +0.1% | +14.1% | +34.4% | -37.7% | +40.4% | +22.3% | +22.0% | -8.6% | +11.7% | |
| – | +35.4% | +21.3% | +1.2% | +15.7% | +36.0% | -37.6% | +27.2% | +25.6% | +24.4% | -8.9% | +12.4% | |
| – | +6.9% | +7.0% | +4.4% | +3.1% | +3.1% | -12.5% | +12.5% | +1.3% | -3.8% | -14.9% | -31.0% | |
| – | +22.2% | +183.8% | -43.1% | -38.3% | +66.1% | -96.6% | +518.5% | +271.9% | +166.4% | -59.8% | -55.2% | |
| – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -7.7% | -6.9% | -3.9% | -12.4% | +105.6% | -6.2% | -10.0% | -10.9% | +55.6% | +0.4% | -10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +21.8% | +1.4% | +1.3% | +1.7% | +2.6% | +45.4% | +0.1% | +0.3% | +6.5% | +12.6% | +1.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.